Operating Lease, Payments of Taysha Gene Therapies, Inc. from 31 Mar 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Taysha Gene Therapies, Inc. annual and quarterly Operating Lease, Payments in USD history and change rate from 31 Mar 2022 to 31 Dec 2024.
  • Taysha Gene Therapies, Inc. Operating Lease, Payments for the quarter ending 31 Mar 2024 was $2,742,000, a 296% increase year-over-year.
  • Taysha Gene Therapies, Inc. annual Operating Lease, Payments for 2024 was $2,815,000, a 0.32% decline from 2023.
  • Taysha Gene Therapies, Inc. annual Operating Lease, Payments for 2023 was $2,824,000, a 14% increase from 2022.
Source SEC data
View on sec.gov
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)

Taysha Gene Therapies, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,815,000 -$9,000 -0.32% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
2023 $2,824,000 +$338,000 +14% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
2022 $2,486,000 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY

Taysha Gene Therapies, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $2,742,000 +$2,050,000 +296% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q1 2023 $692,000 +$329,000 +91% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $363,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.